SAGE Otolaryngology   /     OTO: Clinical Practice Guideline: Immunotherapy for Inhalant Allergy, Part 2

Description

Editor in Chief Cecelia E. Schmalbach, MD, MSc, is joined by lead author Richard K. Gurgel, MD, MSC, and author Stacey L. Ishman, MD, MPH for a discussion of the implications for otolaryngologists of the “Clinical Practice Guideline on Immunotherapy for Inhalant Allergy,” which published in the March 2024 issue of Otolaryngology–Head and Neck Surgery. They discuss how the CPG came together over two years and what they discovered comparing different types of immunotherapy and the effects on different patient populations.  Click here to read the full article.

Subtitle
Editor in Chief Cecelia E. Schmalbach, MD, MSc, is joined by lead author Richard K. Gurgel, MD, MSC, and author Stacey L. Ishman, MD, MPH for a discussion of the implications for otolaryngologists of the “Clinical Practice Guideline on Immunotherapy...
Duration
19:39
Publishing date
2024-03-14 15:03
Link
https://sites.libsyn.com/54812/oto-clinical-practice-guideline-immunotherapy-for-inhalant-allergy-part-2
Contributors
Enclosures
https://traffic.libsyn.com/secure/sageotolaryngology/Part_2.mp3?dest-id=201698
audio/mpeg

Shownotes

Editor in Chief Cecelia E. Schmalbach, MD, MSc, is joined by lead author Richard K. Gurgel, MD, MSC, and author Stacey L. Ishman, MD, MPH for a discussion of the implications for otolaryngologists of the “Clinical Practice Guideline on Immunotherapy for Inhalant Allergy,” which published in the March 2024 issue of Otolaryngology–Head and Neck Surgery. They discuss how the CPG came together over two years and what they discovered comparing different types of immunotherapy and the effects on different patient populations. 

Click here to read the full article.